CBAY - Cymabay Therapeu - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $36.94. This is a potential upside of $4.46 (13.73%) from yesterday's end of day stock price of $32.48.

Cymabay Therapeu's activity chart (see below) currently has 183 price targets and 127 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.08% with an average time for these price targets to be met of 713.5 days.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 28-Feb-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$32.5

$0.02 (0.06%)

1 years 7 months 11 days ago
(28-Feb-2024)

17/18 (94.44%)

$0.31 (0.96%)

627

Hold

$32.5

$0.02 (0.06%)

$12

1 years 7 months 20 days ago
(19-Feb-2024)

2/3 (66.67%)

$0.3 (0.93%)

129

Hold

$32.5

$0.02 (0.06%)

$25

1 years 7 months 26 days ago
(13-Feb-2024)

8/9 (88.89%)

$0.32 (0.99%)

891

Hold

$32.5

$0.02 (0.06%)

$34

1 years 7 months 27 days ago
(12-Feb-2024)

9/12 (75%)

$0.38 (1.18%)

1210

Hold

$32.5

$0.02 (0.06%)

$33

1 years 7 months 27 days ago
(12-Feb-2024)

13/15 (86.67%)

$0.38 (1.18%)

908

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CBAY (Cymabay Therapeu) average time for price targets to be met?

On average it took 713.5 days on average for the stock forecasts to be realized with a an average price target met ratio 84.08

Which analyst has the current highest performing score on CBAY (Cymabay Therapeu) with a proven track record?

PASHA SARRAF

Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?

Pasha Sarraf has 3 price targets and 2 ratings on CBAY

Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?

Kristen Kluska with highest potential upside - $0.02

Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?

Joel Beatty with lowest potential downside - -$22.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?